SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-107687
Filing Date
2024-10-10
Accepted
2024-10-10 15:14:44
Documents
4
Period of Report
2024-10-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2424074d4_6k.htm 6-K 9790
2 EXHIBIT 99.1 tm2424074d4_ex99-1.htm EX-99.1 10279
3 GRAPHIC tm2424074d4_ex99-1img01.jpg GRAPHIC 6082
4 GRAPHIC tm2424074d4_ex99-1img02.jpg GRAPHIC 3480
  Complete submission text file 0001104659-24-107687.txt   34639
Mailing Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5
Business Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 289-910-0850
Cardiol Therapeutics Inc. (Filer) CIK: 0001702123 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40712 | Film No.: 241365002
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)